The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Chronic Caffeine Consumption Prevents Memory Disturbance in Different Animal Models of Memory Decline
Open accessAbstract
Caffeine, the most widely consumed psychoactive drug, enhances attention/vigilance, stabilizes mood, and might also independently enhance cognitive performance. Notably, caffeine displays clearer and more robust beneficial effects on memory performance when memory is perturbed by stressful or noxious stimuli either in human or animal studies. Thus, caffeine restores memory performance in sleep-deprived or aged human individuals, a finding replicated in rodent animal models. Likewise, in animal models of Alzheimer's disease (AD), caffeine alleviates memory dysfunction, which is in accordance with the tentative inverse correlation between caffeine intake and the incidence of AD in different (but not all) cohorts. Caffeine also affords beneficial effects in animal models of conditions expected to impair memory performance such as Parkinson's disease, chronic stress, type 2 diabetes, attention deficit and hyperactivity disorder, early life convulsions, or alcohol-induced amnesia. Thus, caffeine should not be viewed as a cognitive enhancer but instead as a cognitive normalizer. Interestingly, these beneficial effects of caffeine on stress-induced memory disturbance are mimicked by antagonists of adenosine A2A receptors. This prominent role of A2A receptors in preventing memory deterioration is probably related to the synaptic localization of this receptor in limbic areas and its ability to control glutamatergic transmission, especially NMDA receptor-dependent plasticity, and to control apoptosis, brain metabolism, and the burden of neuroinflammation. This opens the real and exciting possibility that caffeine consumption might be a prophylactic strategy and A2A receptor antagonists may be a novel therapeutic option to manage memory dysfunction both in AD and in other chronic neurodegenerative disorders where memory deficits occur.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 7×
“tagonise adenosine receptors (see [1]).”
BackgroundInfluentialRisk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×
“In contrast to A1 receptors, which seem to be activated by astrocytic-derived adenosine [73], A 2A receptors are activated by ATP-derived adenosine [72, 74], which is released in greater amounts by synapses stimulated upon high-frequency [75–77].”
BackgroundCharacterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170
Sleep-Dependent Learning and Memory Consolidation
Walker, M. P., & Stickgold, R. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.031 · Cited by 1,113 · cited 1×
“A recent elegant study showed that the administration of caffeine (5 mg/kg) prevented ethanol-induced retrograde amnesia in rats [54]; interestingly, this effect could be mimicked by a combination of a phosphodiesterase 5 inhibitor (zapri- nast, 10 mg/kg) together with an A2A receptor antagonist…”
BackgroundWalker, M. P., & Stickgold, R. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070307 · Cited by 1,075 · cited 1×
“A recent elegant study showed that the administration of caffeine (5 mg/kg) prevented ethanol-induced retrograde amnesia in rats [54]; interestingly, this effect could be mimicked by a combination of a phosphodiesterase 5 inhibitor (zapri- nast, 10 mg/kg) together with an A2A receptor antagonist…”
BackgroundHippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“Since the loss of synapses in cortical regions is the earliest morphological modification in AD (see [214, 215]), as well as in mild cognitive impairment [216, 217], these results further strength the suggestion that caffeine and A2A receptor antagonists may be a novel promising prophylactic and/or therapeutic option…”
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 4×
“In fact, the intake of caffeine is inversely correlated with the incidence of Parkinson’s disease in different cohorts [111–115], and A2A receptor antagonists (or A2A receptor gene deletion) attenuate motor impairment in different animal models of Parkinson’s disease [116–118].”
BackgroundInfluentialProspective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review
van Dam, R. M., & Hu, F. B. (2005) · JAMA · doi:10.1001/jama.294.1.97 · Cited by 662 · cited 1×
“burst of interest (see [142]) and we have found that the”
Backgroundde Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629
Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 1×
“chondria suffer morphological changes upon exposure to glutamate [253].”
BackgroundAn Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440 · cited 1×
“Furthermore, evidence is accumulating suggesting that the chronic consumption of caffeine mostly acts by antagonizing A2A rather than A1 receptors [107,108], as first suggested by Daly and Fredholm [58].”
BackgroundGABAergic network activation of glial cells underlies hippocampal heterosynaptic depression
Serrano, A., Haddjeri, N., Lacaille, J.-C., & Robitaille, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5255-05.2006 · Cited by 398
Rebola, N., Lujan, R., Cunha, R. A., & Mulle, C. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.023 · Cited by 376
Self-citationHaskell, C. F., Kennedy, D. O., Wesnes, K. A., & Scholey, A. B. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2104-3 · Cited by 356
Smit, H. J., & Rogers, P. J. (2000) · Psychopharmacology · doi:10.1007/s002130000506 · Cited by 339 · cited 1×
“concluded that caffeine consumed either acutely [9,11, 13,21–24], with continuous slow delivery [25,26] or with long-term intermittent consumption [27–31] enhances memory performance in healthy volunteers.”
BackgroundAssociation between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman, P., Federoff, H., & Kurlan, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140626.48118.0a · Cited by 314
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Rétey, J. V., Adam, M., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100102 · Cited by 278
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250 · cited 1×
“sive rats [157]; these animals display memory deficits before the onset of measurable tensional changes and the administration of caffeine prevents the deficits in memory performance [158], in a manner mimicked by adenosine A2A receptors antagonists [159,160].”
BackgroundDoes caffeine intake enhance absolute levels of cognitive performance?
Jarvis, M. J. (1993) · Psychopharmacology · doi:10.1007/bf02246949 · Cited by 249 · cited 1×
“Likewise, caffeine has significantly greater beneficial effects on cognition in aged individuals [11,27,29]; but see [7, 28], and is able to attenuate the age-associated cognitive decline [189]; but see [34].”
BackgroundSmoking, alcohol, and coffee consumption preceding Parkinson’s disease: A case-control study
Benedetti, M. D., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000) · Neurology · doi:10.1212/wnl.55.9.1350 · Cited by 234
Ascherio, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh312 · Cited by 232
Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation
James, J. E., & Rogers, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0084-6 · Cited by 231 · cited 1×
“concluded that caffeine consumed either acutely [9,11, 13,21–24], with continuous slow delivery [25,26] or with long-term intermittent consumption [27–31] enhances memory performance in healthy volunteers.”
BackgroundChilds, E., & de Wit, H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0341-3 · Cited by 219
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182
Coffee Consumption and Cognitive Function among Older Adults
Johnson-Kozlow, M. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf119 · Cited by 173 · cited 1×
“Likewise, caffeine has significantly greater beneficial effects on cognition in aged individuals [11,27,29]; but see [7, 28], and is able to attenuate the age-associated cognitive decline [189]; but see [34].”
BackgroundCaffeine attenuates scopolamine-induced memory impairment in humans
Reidel, W., Hogervorst, E., Leboux, R., Verhey, F., van Praag, H., & Jolles, J. (1995) · Psychopharmacology · doi:10.1007/bf02246090 · Cited by 152
Van Dort, C. J., Baghdoyan, H. A., & Lydic, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4111-08.2009 · Cited by 143
Liu, J., Lu, W., Reigada, D., Nguyen, J., Laties, A. M., & Mitchell, C. H. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0675 · Cited by 141
Hameleers, P. A. H. M., Van Boxtel, M. P. J., Hogervorst, E., Riedel, W. J., Houx, P. J., Buntinx, F., & Jolles, J. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.218 · Cited by 134
Rogers, P. J., Heatherley, S. V., Hayward, R. C., Seers, H. E., Hill, J., & Kane, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2097-y · Cited by 132 · cited 2×
“This is in notable accordance with the observation that caffeine has robust effects on cognition in sleep-deprived individuals [25, 26,85], which may be different from other psychostimulants [173].”
ResultKillgore, W. D. S., Kahn-Greene, E. T., Grugle, N. L., Killgore, D. B., & Balkin, T. J. (2009) · Sleep · doi:10.1093/sleep/32.2.205 · Cited by 132
Mitochondrial Dysfunction and Dendritic Beading during Neuronal Toxicity
Greenwood, S. M., Mizielinska, S. M., Frenguelli, B. G., Harvey, J., & Connolly, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704488200 · Cited by 128
Huang, C.-C., Liang, Y.-C., & Hsu, K.-S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09728.1999 · Cited by 127
Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences
Adan, A., Prat, G., Fabbri, M., & Sànchez-Turet, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.005 · Cited by 113 · cited 1×
“females [103,112–114,189,309–314].”
The effects of habitual caffeine use on cognitive change: a longitudinal perspective
VANBOXTEL, M., SCHMITT, J., BOSMA, H., & JOLLES, J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00171-0 · Cited by 110
Arnold, L. E. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280073008 · Cited by 104 · cited 1×
“Thus, caffeine has been considered as a therapeutic option for ADHD, but the results have been inconsistent [147,149–154], probably because the dose schedule of caffeine administration has not been matched to the modified pharmacokinetic profile of caffeine in children (see [155,156]).”
ResultCaffeine, cognitive failures and health in a non‐working community sample
Smith, A. P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.991 · Cited by 102 · cited 2×
“attenuate the impairment of mood-related behavior in mice subject to chronic stress [126], this suggests that caffeine may not only be a normalizer of stress-induced memory impairment, but also a mood normalizer [131] reviewed in [18].”
BackgroundThe influences of age and caffeine on psychomotor and cognitive function
Rees, K., Allen, D., & Lader, M. (1999) · Psychopharmacology · doi:10.1007/s002130051047 · Cited by 101 · cited 1×
“Likewise, caffeine has significantly greater beneficial effects on cognition in aged individuals [11,27,29]; but see [7, 28], and is able to attenuate the age-associated cognitive decline [189]; but see [34].”
BackgroundSteptoe, A., Gibson, E. L., Vounonvirta, R., Williams, E. D., Hamer, M., Rycroft, J. A., Erusalimsky, J. D., & Wardle, J. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0573-2 · Cited by 91
Killgore, W. D. S., Muckle, A. E., Grugle, N. L., Killgore, D. B., & Balkin, T. J. (2008) · International Journal of Neuroscience · doi:10.1080/00207450802323970 · Cited by 26 · cited 1×
“females [103,112–114,189,309–314].”
Cited by
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210215655 · Cited by 631
“While caffeine seems to prevent or restore memory impairment due to disturbances in brain homeostasis [7], its cognition-enhancing properties are still a matter of debate [8, 9].”
BackgroundHow does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Self-citationAdenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Self-citationThe role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y.-K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 410
Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423088112 · Cited by 312
Self-citation
Metadata
- Authors
- Cunha, R. A., & Agostinho, P. M.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-04-14
- Volume
- 20
- Issue
- s1
- Pages
- S95-S116
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1514696983
- Cited by
- 232
- References
- 50
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.